ACE Obesity project : Modelling cost-effectiveness and population impacts in obesity prevention by Haby, M et al.
          Deakin Research Online 
 
This is the published version:  
 
Haby, M, Carter, R, Markwick, A, Moodie, M, Magnus, A, Vos, T and Swinburn, B 2006, 
ACE Obesity project : Modelling cost-effectiveness and population impacts in obesity 
prevention, in ICO Satellite 2006 : Presentations of the Community Based Obesity 
Prevention Satellite, International Association for the Study of Obesity, [London, England].      
  
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30025651 
 
Reproduced with the kind permissions of the copyright owner. 
 
Copyright : 2006, International Association for the Study of Obesity 
1
Assessing Cost Effectiveness Studies
ACE-Obesity project: Modelling 
cost-effectiveness & population 
impacts in obesity prevention
Speaker: A/Professor Rob Carter
Authors: Haby M, Carter R, Marwick A, Moodie M, Magnus A, Vos T, Swinburn B
Community Based Obesity Prevention ICO Satellite, Geelong 2006
2
Assessing Cost Effectiveness Studies
Plan of Talk
1. Brief history of ACE research program 
2. Locate ACE approach in context of 
international literature
3. Overview ACE approach to priority 
setting 
4. Present findings from the ACE: Obesity  
study
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1) Brief History: Assessing Cost-
Effectiveness (ACE) studies
• Pilot study: ACE-Cancer (Australian
government, 2000-2001)
 evaluated 7 cancer control interventions
• ACE: Heart Disease (NHMRC, 2000-2003)
 20 + interventions for prevention of CHD
• ACE: Mental Health (Aust/Vic govt 2001-04)
 20 + interventions for depression, 
schizophrenia, anxiety and ADHD
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1) Brief History: Assessing Cost-
Effectiveness (ACE) studies
• ACE: Obesity (Vic govt 2004-2006)
 12+ interventions; focus on prevention and 
childhood interventions
• ACE: Prevention (NHMRC 2005-2009)
 150 interventions for both Indigenous and non 
Indigenous populations
• ACE funded by government & competitive grants, 
covering range of diseases & decision contexts
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2) International literature
• Next, I’d like to locate ‘ACE’ within 
international literature on priority setting
• There have been important attempts to 
develop theoretical base for priority setting
– within the economics discipline
– but also from other disciplines
• Philosophy (“fair innings” approaches); 
• Behavioural Science (consensus-based 
approaches); 
• Epidemiology (needs-based approaches)
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2) Literature on priority setting
• Key issues to emerge from the 
literature
– ‘explicit’ verses ‘implicit’ approaches
– how explicitness in priority setting 
should be achieved
– ‘technical school’ verses ‘due 
process’
• appeal of a combined approach has 
driven the development of ACE
7
Assessing Cost Effectiveness Studies
3) Tried to achieve this with ACE
1. Clear process for selection of interventions
2. Standardised evaluation methods to minimize 
methodological confounding
3. Evaluation conducted as integral part of priority 
setting exercise (not collation from literature)
4. Evidence-based approach with extensive 
uncertainty & sensitivity testing 
5. Information assembled by multi-disciplinary 
research team, working to stakeholders
6. Careful thought given to concept of “benefit” and 
its measurement
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3) Defining “benefit” to reflect policy aims
Typical policy objectives in Australia are:
1. Size of the problem (i.e. where can the biggest 
difference be made?)
2. Efficacy/effectiveness of the intervention (i.e. 
quality and nature  of the available evidence?)
3. Capacity to reduce inequity in health status?
4. Efficiency of the intervention?
5. Cost of the intervention (i.e. ‘affordability’)
6. Acceptance by stakeholders, particularly the 
general community
7. Likelihood of successful implementation (i.e. 
‘feasibility’ issues)
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3) From policy to measurement of “benefit”
• Two-stage approach adopted in ACE
– first, a measure of health gain in relation to 
resources consumed ($ cost per DALY)
– second, explicitly provide for judgement based 
on broader considerations (‘2nd stage filters’) 
not easily reflected in CEA “decision rules”
• Objectives of efficacy/effectiveness and efficiency 
can be picked in the “Cost per DALY” ratio (1st
stage measure)
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3) From policy to measurement of ‘benefit’
• 2nd stage filters designed to pick up the 
other policy objectives 
– strength of the ‘evidence’ base; 
– size & importance of the problem 
addressed; 
– acceptability & feasibility of 
implementation; 
– equity (who receives the health gain?)
– Other? (cultural integrity; empowerment; 
healthy community, etc)
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3) Rationale for 2nd Stage Filters
• Purpose of 2nd stage filters is to incorporate:
– broader dimensions of benefit (i.e. of “value” in the 
“value-for-money” notion underlying economics) 
– objectives & underlying principles of government 
policy
– impact on stakeholders  (“due process”)
– sensible interpretation of “cost per DALY” findings
– initial consideration of implementation & change 
management
• And to do so in an explicit & accountable way
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3) Recap: Why ACE as priority setting approach?
• Relevance:
– enables focus on relevant options for change
– recognises broader policy issues
• Rigour:
– applies key concepts of economic analysis
– avoids methodological confounding 
– evidence-based approach with extensive sensitivity/ 
uncertainty testing
– evaluation conducted as part of priority setting process
• Due process:
– involves stakeholders
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4) ACE: Obesity ~ Background
• Growing profile of obesity as a key issue of   
public health significance
• Governments are committing funds to obesity   
decisions with insufficient evidence available to 
guide them
• ACE Project funded by Vic Department of 
Human Services (Jan 2004 – Dec 2006)
• To inform policy-making at a national and state 
level
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Aim of the ACE-Obesity project
“To assess from a societal perspective 
the most cost-effective options for 
preventing unhealthy weight gain  in 
Australia, particularly amongst 
children and adolescents.”
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Economic protocol in ACE: Obesity
Perspective Societal
Comparator “current practice” / no intervention
Target population Australian population 2001
Time horizon Intervention time period 
reflects its real-life application 
Costs & benefits tracked for 100 yrs or till death
Discounting 3%
Study design CEA – “cost per BMI unit saved”
CUA – “cost per DALY saved”
2nd Stage Equity,  strength of evidence,  feasibility,
filters acceptability to stakeholders, sustainability,
positive & negative side-effects
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Economic protocol in ACE: Obesity
Costs Range of sources, expressed as real costs in 2001
Cost-offsets Matched to health gain modelling methodology
Incorporated AIHW costs of illness estimates - IHD, 
ischaemic stroke, hypertensive heart disease, type 2
diabetes, osteoarthritis, cancers (endometrial, colon, 
kidney and post-menopausal breast cancer)
Uncertainty analysis
Calculated 95% uncertainty interventions around ICERs
Monte Carlo simulations using @RISK software
Expert Working Group
Active role in selecting interventions, defining filter 
criteria, and critically examining models
Research team Epidemiologists and health economists - conducted
C/E analyses using the best available evidence
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Intervention selection criteria
• Relevance to current policy decision-making
• Availability of evidence for efficacy/effectiveness
• Potential impact on addressing obesity problem
• Ability to clearly specify intervention pathway
• Inclusion of a mix of interventions and settings
• Considerations of program logic
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Interventions selected for analysis
by ‘Healthy Weight 2008’ Settings
Child Care and 1. Active After School Communities program
Schools 2. Multi-faceted School-based program (- PE)
3. Multi-faceted School-based program (+ PE)
4. Multi-faceted School-based program targeted at  
overweight and obese children
5. Education program to reduce fizzy drink
consumption
6. Education program to reduce TV viewing
Neighbourhood
and Community       
Organisations 7. TravelSMART Schools
8. Walking School Bus
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Interventions selected for analysis
Media and 9.  Reduction of TV advertising of high fat and/or high
Marketing sugar foods and drinks to children (up to 14 yrs)
Primary Care 10.  Family-based GP program for overweight and 
mildly obese children
11.  Family-based targeted program for obese children
12.  Orlistat therapy for obese adolescents
Hospital 13.  Gastric banding for morbidly obese adolescents
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Incremental cost-effectiveness of interventions 
(net $ per DALY saved)
$0 $10
$20
$30
$40
$50
$60
$70
$80
TV advertising
Targeted multi-faceted school-based
Family-based targeted
Fizzy drinks
Multi-faceted school-based + PE
TV viewing
Gastric banding
Multi-faceted school-based - PE
GP intervention
Orlistat in adolescents
Active After School
TravelSMART
Walking School Bus
Thousands
Cost-effective Not cost-effective
> $0.76M
> $0.25M
Group of six “dominant” 
interventions
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$22.6M$22.8M3016,0000.03Walking School Bus
$12.5M$13.1M50268,0000.07TravelSMART
$36.6M$40.3M44999,0000.07Active After-School
$11.2M$24.3M1,600115,0000.31Multi-faceted school-based -PE
$4.0M$6.4M4503,3000.86Orlistat in adolescents
$3.0M$6.3M5119,7000.25GP intervention
$55.0M$130M123004,10013.9Gastric banding
-$28.7M$40.4M8,000115,0001.1Multi-faceted school-based +PE
-$2.1M$54.6M6,700227,0000.45TV viewing
-$5.2M$3.3M1,060119,0000.13Fizzy drinks
-$0.08$0.56M3704,3000.52Targeted multi-faceted 
school-based 
-$4.1M$11M2,7005,8001.7Family-based targeted 
program
-$300M$0.13M370002.4 M0.17TV advertising
Net 
Cost
Gross 
Cost
DALYsTarget 
pop’n
BMI per 
person
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Total DALY benefit versus strength of the evidence
Active After-
School
TravelSMART
Walking 
School Bus
Orlistat500
Multi-faceted 
school based–PE
Targeted multi-
faceted school
GP intervention
3 000
TV viewingMulti-faceted 
school-based +PE
Fizzy drinks
LAGB
Targeted 
family-based
20 000Total
DALY
Benefit
TV 
advertis
ing
Ideal 
Spot
40 000
No 
evidenceWeakLimited
Strong 
evidence of 
effectiveness
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CEA Results + 2nd stage filters
• Excellent buys (cost-saving)
¾ TV advertising
- acceptability to C’w Govt
¾ Family-based targeted program for obese children
- acceptability, feasibility
¾ Targeted multi-faceted school-based program
- acceptability, sustainability
¾ Fizzy drinks
- acceptability (Dept Education), feasibility
¾ TV viewing
- acceptability (Dept Education), feasibility, evidence
¾ Multi-faceted school-based + PE
- acceptability (Dept Education), feasibility
24
Assessing Cost Effectiveness Studies
CEA Results + 2nd stage filters
• Good buys (<$50,000 per DALY)
¾ Gastric banding
- equity, acceptability
¾ GP intervention for overweight and mildly obese children
- evidence
¾ Orlistat in adolescents
- equity, acceptability
¾ Multi-faceted school-based - PE
- acceptability (Dept Education), feasibility
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CEA Results + 2nd stage filters
• Weak buys under current assumptions
(>$50,000 per DALY)
¾ Active After School Communities
- evidence, sustainability
¾ TravelSMART
- feasibility, sustainability
¾ Walking School Bus
- evidence, feasibility, sustainability
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Walking School Bus – Sensitivity testing
Scenarios to improve C/E
Base case
Reduce costs
Attribute 50% costs to other objectives
Annuitise fixed costs
Improve capacity utilisation/participation
↑ no. children per WSB from 7 to 10
↑ no. WSB per school from 1.6 to 3
↑ no. schools per Council from 4 to 6
↑ % non-Vict. Councils from 50% to 65%
Increase participants receiving benefit
↑ % new to active transport from 50 to 65%
More optimistic scenario (cumulative)
Net cost per DALY
$0.76M ($0.23M; $3.32M)
$0.37M ($0.1M: $1.5M)
$0.36M ($0.11M; $1.5M)
$0.26M ($82,000; $1M)
$0.16M ($57,000; $0.59M)
$0.12M ($45,000; $0.4M)
$0.118M ($43,000; $0.4M)
$86,000 ($35,000; $0.29M)
$20,000 ($4,400; $83,000)
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Concluding Comments
• There are cost-effective obesity prevention interventions.
• Some interventions have potential to save money in the 
longer term – mostly public health interventions.
• Restricting TV advertising to children of high fat and/or 
high sugar drinks is the most cost-effective intervention.
• Multi-faceted school-based programs save money if 
include increased active PE component. Targeted 
programs also save money but less acceptable.
28
Assessing Cost Effectiveness Studies
Concluding Comments
• Education to reduce consumption of fizzy drinks likely to 
be cost-saving.
• Physical activity interventions were not good buys in their 
current form. Need to ↑ amount of PA, ↑ recruitment and ↓ 
costs to become cost-effective.
• Application of 2nd stage filter criteria highlight issues that 
require attention if an intervention is to be implemented.
• Results assume 100% maintenance of BMI benefit into 
adulthood. If reduced to 50%, ICERs would ~ double.
29
Assessing Cost Effectiveness Studies
Concluding Comments
• Evidence for some interventions is still weak.
• Quality of public health evaluations needs to be improved if 
they are to contribute to evidence-based decision-making.
• Not all obesity prevention interventions could be evaluated 
within ACE-Obesity. 
• Is our armoury of current interventions sufficient to reverse 
the trend towards increasing BMI?
• More evidence needed for other types of interventions 
(taxes and subsidies on food) and in other settings 
(maternal and infant health services).
